Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket

Author: Lisa Levin | February 21, 2023 08:48am

Gainers

• Troika Media Group Inc (NASDAQ:TRKA) shares rose 65.9% to $0.37 in pre-market trading after dropping 4% on Friday.
• Owlet Inc (NYSE:OWLT) rose 45.3% to $0.50 in pre-market trading after reporting a $30 million private placement financing.
• Sigma Lithium Corp (NASDAQ:SGML) rose 26.7% to $37.35 in pre-market trading. Sigma Lithium, during January, filed NI 43-101 technical report for production expansion supporting the previously announced 60% increase in
• mineral reserves and $15.3 billion NPV.
• Arbe Robotics Ltd (NASDAQ:ARBE) rose 19.5% to $5.20 in pre-market trading after gaining 12% on Friday.
• Actinium Pharmaceuticals Inc (NYSE:ATNM) rose 18% to $16.24 in pre-market trading. Actinium recently signed a cooperative research and development agreement with National Cancer Institute to further enhance clinical and non-clinical development of actimab-A for the treatment of acute myeloid leukemia and other hematologic malignancies.
• Apellis Pharmaceuticals Inc (NASDAQ:APLS) shares rose 13.4% to $62.99 in pre-market trading after the company said that the FDA approved SYFOVRE as first and only treatment for geographic atrophy.
• Connexa Sports Technologies Inc (NASDAQ:CNXA) rose 11.7% to $0.27 in pre-market trading.
• Aurora Mobile Ltd - ADR (NASDAQ:JG) shares rose 10.3% to $0.75 in pre-market trading. Aurora Mobile recently partnered with Shengshi Dalian Automobile to explore automobile butler service market.
• MDxHealth SA - ADR (NASDAQ:MDXH) rose 9.2% to $4.29 in pre-market trading. The company, last month, reaffirmed FY23 sales guidance of $65 million to $70 million.
• Zedge, Inc. (NYSE:ZDGE) rose 7% to $2.89 in pre-market trading. Zedge, during December, posted a Q1 loss of $0.01 per share.

Losers

• iBio, Inc. (NYSE:IBIO) shares fell 13.5% to $1.28 in pre-market trading. iBio shares jumped over 97% on Friday after the company announced MUC16 as its latest immune-oncology target program.
• Vinco Ventures, Inc. (NASDAQ:BBIG) shares dropped 11.4% to $0.5110 in pre-market trading. VVIP Ventures recently entered into an Asset Purchase Agreement with magazine publisher a360 Media to acquire the National Enquirer, the National Examiner and Globe. VVIP Ventures is a joint venture between Vinco Ventures and ICON Publishing, LLC.
• Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 10% to $0.7140 in pre-market trading after climbing over 10% on Friday.
• Sorrento Therapeutics, Inc. (NASDAQ:SRNE) fell 9.7% to $0.2799 in pre-market trading after jumping 20% on Friday.
• JD.com, Inc. (NASDAQ:JD) fell 8.1% to $48.72 in pre-market following a media report that the company is planning a $1.5 billion subsidy campaign to compete against rivals.
• OKYO Pharma Limited (NASDAQ:OKYO) fell 7.7% to $3.45 in pre-market trading after surging 58% on Friday. OKYO Pharma, during December, announced U.S. FDA clearance of IND application for OK-101 for the treatment of dry eye disease.
• GeneDx Holdings Corp. (NASDAQ:WGS) fell 7.7% to $0.48 in pre-market trading.
• EBET, Inc. (NASDAQ:EBET) fell 6.4% to $0.55 in pre-market trading. EBET shares gained over 10% on Friday following strong Q4 results and guidance from DraftKings.
• SciSparc Ltd. (NASDAQ:SPRC) fell 5.5% to $0.9452 in pre-market trading. SciSparc shares gained around 10% on Friday after the company announced its MitoCareX Bio joint venture achieved achieved its first milestone pursuant to the March 10, 2022 Founders and Investment Agreement.
• NexImmune, Inc. (NASDAQ:NEXI) shares fell 5.1% to $0.5599 in pre-market trading. NexImmune recently announced data showing AIM ACT T cells enhance the response to bispecific T cell engager therapy at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR.

Now Read This: Fear & Greed Index Remains In 'Greed' Zone After Dow Gains Over 100 Points

Posted In: APLS ARBE ATNM BBIG CNXA EBET IBIO JD JG MDXH NEXI OKYO OWLT SGML SPRC SRNE TRKA VLON WGS ZDGE